Polaryx Therapeutics (PLYX)
Develops PLX-200 and other candidates for rare pediatric lysosomal storage disorders.
$2.02
Pre-market−0.01 (−0.49%)
At close$2.03(+2.53%)
Something off on this page? Send us feedback.
EPSReportedEstimate
————Jan '26Mar '26May '26Aug '26
Reported————−$0.03−$0.13−$0.05−$0.03
Estimate—————−$0.02−$0.02−$0.04
Surprise—————−550.0%−150.0%+14.3%
RevenueReportedEstimate
————Jan '26Mar '26May '26Aug '26
Reported————————
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.04 | −$0.03 | +14.3% |
| May 2026 | −$0.02 | −$0.05 | −150.0% |
| Mar 2026 | −$0.02 | −$0.13 | −550.0% |
| Jan 2026 | — | −$0.03 | — |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | −$0.04 | −$0.03 | +14.3% | — | — | — | +12.1% |
| May 15, 2026 | −$0.02 | −$0.05 | −150.0% | — | — | — | +3.4% |
| Mar 24, 2026 | −$0.02 | −$0.13 | −550.0% | — | — | — | −2.5% |
| Jan 27, 2026 | — | −$0.03 | — | — | — | — | — |